Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

644379.pdf (1.48 MB)

Document type

Article

Version

Published version

Publication date

2014-07-14

Publication license

cc-by (c) Guzman-Aranguez, A. et al., 2014
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/60525

Purinergic receptors in ocular inflammation

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1155/2014/320906

Abstract

Inflammation is a complex process that implies the interaction between cells and molecular mediators, which, when not properly 'tuned,' can lead to disease. When inflammation affects the eye, it can produce severe disorders affecting the superficial and internal parts of the visual organ. The nucleoside adenosine and nucleotides including adenine mononucleotides like ADP and ATP and dinucleotides such as P(1),P(4)-diadenosine tetraphosphate (Ap4A), and P(1),P(5)-diadenosine pentaphosphate (Ap5A) are present in different ocular locations and therefore they may contribute/modulate inflammatory processes. Adenosine receptors, in particular A2A adenosine receptors, present anti-inflammatory action in acute and chronic retinal inflammation. Regarding the A3 receptor, selective agonists like N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine (CF101) have been used for the treatment of inflammatory ophthalmic diseases such as dry eye and uveoretinitis. Sideways, diverse stimuli (sensory stimulation, large intraocular pressure increases) can produce a release of ATP from ocular sensory innervation or after injury to ocular tissues. Then, ATP will activate purinergic P2 receptors present in sensory nerve endings, the iris, the ciliary body, or other tissues surrounding the anterior chamber of the eye to produce uveitis/endophthalmitis. In summary, adenosine and nucleotides can activate receptors in ocular structures susceptible to suffer from inflammatory processes. This involvement suggests the possible use of purinergic agonists and antagonists as therapeutic targets for ocular inflammation.

Subject

Inflamació, Adenosina, Nucleòtids, Oftalmologia

Subject (English)

Inflammation, Adenosine, Nucleotides, Ophthalmology

Citation

Collections

Articles publicats en revistes (Ciències Fisiològiques)

Citation

GUZMAN-ARANGUEZ, A., et al. Purinergic receptors in ocular inflammation. Mediators of Inflammation. 2014. Vol. 2014, num. 1-11. ISSN 0962-9351. [consulted: 13 of August of 2026]. Available at: https://hdl.handle.net/2445/60525

Export metadata

JSON - METS

Share record